Rare diseases
Investigational molecules
Locations
Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer
DenmarkStudy on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer
DenmarkStudy of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer
DenmarkStudy on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder
DenmarkStudy of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma
DenmarkStudy of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
DenmarkStudy of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer
DenmarkStudy on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy
DenmarkStudy on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia
DenmarkStudy on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa
DenmarkStudy of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer
DenmarkStudy on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
